Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Organic & Biomolecular Chemistry
|
August 7, 2013
Synthesis and biological evaluation of flexible and conformationally constrained LpxC inhibitors
Marius Löppenberg, Hannes Müller, Carla Pulina, et al.
Frontiers in Chemistry
|
May 14, 2023
Editorial: Emerging heterocycles as bioactive compounds
Giovanna Li Petri, Ralph Holl, Virginia Spanò, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 2016
Synthesis and biological evaluation of enantiomerically pure glyceric acid derivatives as LpxC inhibitors
Giovanni Tangherlini, Tullio Torregrossa, Oriana Agoglitta, et al.
Topics in Current Chemistry (Cham)
|
August 10, 2021
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
Giovanna Li Petri, Maria Valeria Raimondi, Virginia Spanò, et al.
Chemmedchem
|
February 26, 2019
Chiral Pool Synthesis, Biological Evaluation and Molecular Docking Studies of C-Furanosidic LpxC Inhibitors
Alexander Dreger, Omar Kharwb, Oriana Agoglitta, et al.
Bioorganic Chemistry
|
November 10, 2021
Synthesis, biological evaluation, and molecular docking studies of deoxygenated C-glycosides as LpxC inhibitors
Alexander Dreger, Katharina Hoff, Oriana Agoglitta, et al.
European Journal of Medicinal Chemistry
|
September 11, 2020
Bioactive pyrrole-based compounds with target selectivity
Giovanna Li Petri, Virginia Spanò, Roberto Spatola, et al.
Bioorganic Chemistry
|
January 11, 2021
Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies
Alexander Dreger, Katharina Hoff, Oriana Agoglitta, et al.
Chemmedchem
|
October 15, 2009
Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring
Ralph Holl, Bettina Jung, Dirk Schepmann, et al.
Archiv Der Pharmazie
|
July 8, 2026
Synthesis, Biological Evaluation, and Molecular Docking Studies of 2r,3t,4c-Configured C-Furanosidic LpxC Inhibitors
André Behnk, Fabian Lüttchens, Frederick Wichter, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Organic & Biomolecular Chemistry
|
August 7, 2013
Synthesis and biological evaluation of flexible and conformationally constrained LpxC inhibitors
Marius Löppenberg, Hannes Müller, Carla Pulina, et al.
Frontiers in Chemistry
|
May 14, 2023
Editorial: Emerging heterocycles as bioactive compounds
Giovanna Li Petri, Ralph Holl, Virginia Spanò, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 2016
Synthesis and biological evaluation of enantiomerically pure glyceric acid derivatives as LpxC inhibitors
Giovanni Tangherlini, Tullio Torregrossa, Oriana Agoglitta, et al.
Topics in Current Chemistry (Cham)
|
August 10, 2021
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
Giovanna Li Petri, Maria Valeria Raimondi, Virginia Spanò, et al.
Chemmedchem
|
February 26, 2019
Chiral Pool Synthesis, Biological Evaluation and Molecular Docking Studies of C-Furanosidic LpxC Inhibitors
Alexander Dreger, Omar Kharwb, Oriana Agoglitta, et al.
Bioorganic Chemistry
|
November 10, 2021
Synthesis, biological evaluation, and molecular docking studies of deoxygenated C-glycosides as LpxC inhibitors
Alexander Dreger, Katharina Hoff, Oriana Agoglitta, et al.
European Journal of Medicinal Chemistry
|
September 11, 2020
Bioactive pyrrole-based compounds with target selectivity
Giovanna Li Petri, Virginia Spanò, Roberto Spatola, et al.
Bioorganic Chemistry
|
January 11, 2021
Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies
Alexander Dreger, Katharina Hoff, Oriana Agoglitta, et al.
Chemmedchem
|
October 15, 2009
Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring
Ralph Holl, Bettina Jung, Dirk Schepmann, et al.
Archiv Der Pharmazie
|
July 8, 2026
Synthesis, Biological Evaluation, and Molecular Docking Studies of 2r,3t,4c-Configured C-Furanosidic LpxC Inhibitors
André Behnk, Fabian Lüttchens, Frederick Wichter, et al.
Page
of 3